Peripheral Neurostimulation for Complex Regional Pain Syndrome
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have a chronic pain condition requiring more than 30 milligrams of morphine equivalent daily, you may not be eligible to participate.
What data supports the effectiveness of the treatment B Braun HNS 12 nerve stimulator for Complex Regional Pain Syndrome?
Research shows that peripheral nerve stimulation, similar to the B Braun HNS 12 nerve stimulator, has been effective in reducing pain for patients with Complex Regional Pain Syndrome. In one study, 63% of patients experienced long-term pain relief, and another case showed significant pain reduction from a score of 8-10 to 1-2 out of 10 after treatment.12345
Is peripheral nerve stimulation safe for humans?
How does the B Braun HNS 12 nerve stimulator treatment differ from other treatments for complex regional pain syndrome?
The B Braun HNS 12 nerve stimulator is unique because it uses peripheral nerve stimulation (PNS), which involves placing electrodes on specific nerves to reduce pain. This method is minimally invasive and can provide long-term pain relief, making it different from other treatments that may not target specific nerves or offer sustained results.123410
What is the purpose of this trial?
Peripheral nerve blocks are routinely used and highly successful for intra-operative anesthesia and post-operative pain management. Nerve blocks are guided using either neurostimulation as a means to localize the right nerve or by ultrasound guidance or combining the 2 methods. The purpose of this study is to assess whether electrical stimulation improves nerve block quality, beyond its simple purpose of nerve localization.
Eligibility Criteria
This trial is for individuals with Complex Regional Pain Syndrome who need nerve blocks for surgery or pain management. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed requirements.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single shot brachial plexus block with or without peripheral nerve stimulation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including sensory/motor block duration and patient satisfaction
Treatment Details
Interventions
- B Braun HNS 12 nerve stimulator
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor